Picciotto M R, Zoli M, Rimondini R, Léna C, Marubio L M, Pich E M, Fuxe K, Changeux J P
CNRS UA D1284, Neurobiologie Moléculaire, Institut Pasteur, Paris, France.
Nature. 1998 Jan 8;391(6663):173-7. doi: 10.1038/34413.
Release of the neurotransmitter dopamine in the mesolimbic system of the brain mediates the reinforcing properties of several drugs of abuse, including nicotine. Here we investigate the contribution of the high-affinity neuronal nicotinic acetylcholine receptor to the effects of nicotine on the mesolimbic dopamine system in mice lacking the beta2 subunit of this receptor. We found that nicotine stimulates dopamine release in the ventral striatum of wild-type mice but not in the ventral striatum of beta2-mutant mice. Using patch-clamp recording, we show that mesencephalic dopaminergic neurons from mice without the beta2 subunit no longer respond to nicotine, and that self-administration of nicotine is attenuated in these mutant mice. Our results strongly support the idea that the beta2-containing neuronal nicotinic acetylcholine receptor is involved in mediating the reinforcing properties of nicotine.
神经递质多巴胺在大脑中脑边缘系统的释放介导了包括尼古丁在内的几种成瘾药物的强化特性。在此,我们研究了高亲和力神经元烟碱型乙酰胆碱受体对缺乏该受体β2亚基的小鼠中脑边缘多巴胺系统中尼古丁作用的影响。我们发现,尼古丁刺激野生型小鼠腹侧纹状体中的多巴胺释放,但不刺激β2突变型小鼠腹侧纹状体中的多巴胺释放。通过膜片钳记录,我们表明没有β2亚基的小鼠的中脑多巴胺能神经元不再对尼古丁作出反应,并且在这些突变小鼠中尼古丁的自我给药减弱。我们的结果有力地支持了这样一种观点,即含β2的神经元烟碱型乙酰胆碱受体参与介导尼古丁的强化特性。